Side-by-side comparison of AI visibility scores, market position, and capabilities
NYSE-listed (GIS) global food company with $19.9B revenue; Cheerios, Betty Crocker, Pillsbury, Blue Buffalo pet food competing with Kellanova and Nestlé while managing GLP-1 drug volume impact.
General Mills is a Minneapolis-based global food company producing packaged foods across breakfast cereals, convenient meals, snacks, baking products, yogurt, and pet food through iconic consumer brands including Cheerios, Wheaties, Betty Crocker, Pillsbury, Yoplait, Nature Valley, Häagen-Dazs, and Blue Buffalo (pet food). Listed on NYSE (NYSE: GIS), General Mills generated approximately $19.9 billion in net sales in fiscal year 2024 (ending May 2024) and employs approximately 33,000 people globally, distributing products in 100+ countries.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.